A new peer-reviewed article developed within the ERAMET project has been published in Clinical and Translational Science: "Co-creating a framework to assess the quality and fitness-for-purpose of real-world data for…
On March 31st and April 1st, the ERAMET project held its second Face-to-Face Consortium Meeting, bringing together representatives from all partner institutions involved in the initiative. Hosted at the University…
The ERAMET project is transforming the development and approval of way drugs for rare and paediatric diseases. are developed and approved. With 30 million people affected by rare conditions across…
ERAMET Contributed to Draft ICH General Principles for MIDD GuidelineThe coordinators of the ERAMET project have actively participated in the development of the Draft ICH General Principles for Model-Informed Drug…
Last November, the ERAMET project was presented at this year’s Pharmacokinetics UK (PKUK) meeting, an important event where experts in drug research gather to share ideas and advancements. This two-day…
The 42° SIF National Congress took place from 13th to 16th November 2024 in Sorrento, Italy, bringing together professionals and researchers in the field of pharmaceutical sciences. During the conference, Silvia Torretta,…
The EU-funded ERAMET project is setting a new standard for the development of orphan and paediatric medicines. With an innovative approach that blends advanced modelling and simulation techniques with real-world…
